European Archives - Page 775 of 995 - European Medical Journal

Continue
9 Mins
8 Aug 2017

Improving Treatment Strategies for Patients with Follicular Lymphoma: How to Translate Novel Study Data into Clinical Practice

Ms Rosmarie Pfau detailed the challenges faced by patients with FL around the world, particularly a desire for improved quality of life (QoL) and…
August 2017

EMJ Hematology 5.1 2017

Welcome to EMJ Hematology 5.1, the latest issue of a series of eJournals designed to present some of the most recent discoveries…
2 Mins
8 Aug 2017

The Simm Study: Survey of Integrative Medicine in Myeloproliferative Neoplasms

In patients with myeloproliferative neoplasms (MPN), including essential thrombocytosis (ET), polycythaemia vera (PV), and myelofibrosis (MF), symptoms…
August 2017

EMJ Hematology 5 [Suppl 10] 2017

This symposium explored the current and future treatment landscape for follicular lymphoma, including those addressing current unmet needs…
11 Mins
8 Aug 2017

Review of the 22nd European Hematology Association Congress 2017

The magnificent city of Madrid, Spain, welcomed this year’s annual European Association of Hematology (EHA) meeting, held from 22nd–25th June 2017.
2 Mins
8 Aug 2017

Targeting Nanoparticles to Chronic Lymphocytic Leukaemia: Exploiting the Properties of CXCR4

A key aim of modern cancer medicine is the improvement of treatment efficacy and overall patient health using targeted therapies.
9 Mins
8 Aug 2017

Shifting Treatment Paradigms in Non-Hodgkin Lymphomas

Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or…
2 Mins
8 Aug 2017

Haemoglobin Level and White Cell Count in Patients Clinically Suspected to have Essential Thrombocythaemia may help in Predicting Early Primary Myelofibrosis or Unclassifiable Myeloproliferative Neoplasm

Accurate diagnosis of essential thrombocythaemia (ET) and differentiation between ET and pre-fibrotic stages of primary myelofibrosis (PMF) can be…
9 Mins
8 Aug 2017

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care

The main objectives of this symposium were to review the value of biosimilars in sustainable treatment for haematologic malignancies and to recognise the…
1 Mins
8 Aug 2017

Front-Line Vascular Access Devices in Peripherally Inserted Acute Leukaemias: Central Catheter Versus Traditional Central Venous Catheter: A Phase IV Randomised Trial

For high-risk haematological patients, in particular those with acute leukaemia, there is limited information on the use of peripherally inserted…